Loading data
CDNANasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 379.81 m USD | 333.79 m USD | 280.32 m USD | 321.79 m USD | 296.4 m USD |
| Research and development expense | 71.43 m USD | 72.51 m USD | 82.42 m USD | 90.39 m USD | 76.53 m USD |
| Operating profit | -30.78 m USD | 40.77 m USD | -203.36 m USD | -77.23 m USD | -29.73 m USD |
| Profit before tax | -21.08 m USD | 52.86 m USD | -190.14 m USD | -76.23 m USD | -32.09 m USD |
| Income tax expense | 271 k USD | 310 k USD | 141 k USD | 379 k USD | -1.43 m USD |
| Net income (reported basis) | -21.35 m USD | 52.55 m USD | -190.28 m USD | -76.61 m USD | -30.66 m USD |
| Net income attributable to common shareholders | -21.35 m USD | 52.55 m USD | -190.28 m USD | -76.61 m USD | -30.66 m USD |
| Basic earnings per share | -0.4 USD/share | 1 USD/share | -3.54 USD/share | -1.44 USD/share | -0.59 USD/share |
| Diluted earnings per share | -0.4 USD/share | 0.93 USD/share | -3.54 USD/share | -1.44 USD/share | -0.59 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.